| 000 | 01017 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518014338.0 | ||
| 264 | 0 | _c20190909 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1778-7254 | ||
| 024 | 7 |
_a10.1016/j.jbspin.2018.12.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSigurdardottir, Valgerdur | |
| 245 | 0 | 0 |
_aRepeated switches between reference product etanercept and biosimilar do not affect disease activity or retention rate of etanercept over 24 months - a cohort study with historical controls. _h[electronic resource] |
| 260 |
_bJoint bone spine _c07 2019 |
||
| 300 |
_a529-530 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aBiosimilar Pharmaceuticals |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRheumatologists |
| 700 | 1 | _aSvärd, Anna | |
| 773 | 0 |
_tJoint bone spine _gvol. 86 _gno. 4 _gp. 529-530 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jbspin.2018.12.003 _zAvailable from publisher's website |
| 999 |
_c29197273 _d29197273 |
||